Search
- Feb 22
Stifel's Paul Matteis covers earnings season and recent clinical data in biotech on Analyst Thursdays
Paul Matteis gives his take on biotech's start to the year and comments on Alnylam, Biogen, Vertex, KalVista, Denali, Acadia, and more.
- Feb 22
Atomic AI's founder on deriving the three-dimensional structure of RNA molecules and leveraging the result for drug discovery
Raphael Townshend describes how the company has used AI and large language models to understand the structure and function of RNA.
- Feb 21
As biotech gravitates to machine learning and AI, insitro's founder shares her experience of working this way since 2018
Daphne Koller describes the platform insitro has been building since it was founded in 2018.
- Feb 15
Wedbush analyst David Nierengarten joins BiotechTV for Analyst Thursdays from San Francisco
David Nierengarten gives his take on biotech and discusses Blueprint Medicines, G1 Therapeutics, Y-mAbs, Fusion Pharma, and more.
- Feb 9
The co-founder of Scion Life Sciences on coming out of stealth mode and the new $310 million venture fund announced this week
Aaron Kantoff describes Scion's mission and investment strategy and shares his thoughts on the current state of biotech.
- Feb 8
Louis Kassa, an expert in the region, gives an overview of the Pennsylvania biopharma ecosystem
The CEO of the Pennsylvania Biotechnology Center, Hepatitis B Foundation, and Blumberg Institute talks about Pennsylvania biotech.